Candid Health secured a $120M Series D to expand an AI-based revenue cycle management (RCM) platform. The round was led by Sixth Street Growth, with participation from Oak HC/FT, 8VC, and Y Combinator, indicating continued investor appetite for automation in healthcare billing and operations. While RCM tools are not therapeutics, they can affect speed of payment, claim integrity, and administrative burden—factors that influence real-world healthcare delivery capacity. For health tech stakeholders, the funding signals that AI-first workflows remain a priority in operational efficiency. The investment also suggests potential scaling pressure on data quality, model performance monitoring, and workflow integration in clinical systems.